Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.41B | 986.30M | 563.80M | 421.00M | 302.60M | Gross Profit |
1.10B | 638.20M | 369.10M | 260.50M | 188.10M | EBIT |
501.90M | 157.20M | 48.70M | 44.90M | 23.60M | EBITDA |
520.00M | 166.90M | 62.90M | 60.90M | 35.60M | Net Income Common Stockholders |
354.60M | 114.00M | 32.90M | 30.90M | 15.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.06B | 11.48B | 7.25B | 1.62B | 2.19B | Total Assets |
15.14B | 11.90B | 7.56B | 4.30B | 2.38B | Total Debt |
224.20M | 249.90M | 78.50M | 78.60M | 49.20M | Net Debt |
-836.90M | -7.43B | -5.98B | -807.10M | -2.03B | Total Liabilities |
14.16B | 11.33B | 7.16B | 4.02B | 2.18B | Stockholders Equity |
979.90M | 576.90M | 409.20M | 285.30M | 196.80M |
Cash Flow | Free Cash Flow | |||
3.24B | 3.91B | 3.13B | 2.05B | 1.17B | Operating Cash Flow |
3.25B | 3.92B | 3.14B | 2.07B | 1.19B | Investing Cash Flow |
-142.60M | -2.59B | -490.40M | -671.80M | -20.90M | Financing Cash Flow |
-125.60M | 153.90M | -1.30M | 24.80M | 31.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £13.30B | 22.24 | 45.06% | ― | 34.39% | 94.35% | |
74 Outperform | £1.46B | 8.35 | 13.14% | 5.47% | 27.88% | 28.92% | |
74 Outperform | £1.06B | 13.21 | 35.03% | 6.15% | 1.64% | 10.85% | |
71 Outperform | £3.29B | 9.59 | 19.85% | 4.96% | 6.34% | 30.64% | |
68 Neutral | £443.84M | 11.30 | 37.39% | 6.18% | 43.88% | 28.50% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% |